A Hungarian team found the world’s most used weed killer inside the lining of the womb — and more of it in women with the harshest form of uterine cancer. That is a measurement. It is not a verdict. The gap between those two words is the story mass outlets flatten and alternative outlets stretch.
On 21 September 2026, Children’s Health Defense’s Defender desk told readers that glyphosate had been found in womb tissue from women with aggressive uterine cancer. The write-up pointed to a real paper, not a rumour. The paper is Presence of glyphosate in endometrial cancer tissue, published in Toxicology Reports (volume 16, 2026). The lead author is Dr Márkó Unicsovics. The work came out of Semmelweis University and the Hungarian University of Agriculture and Life Sciences. PubMed lists it as well: PMID 42088831.
The Defender piece is here: Glyphosate Detected in Womb Tissue of Women With Aggressive Cancer. What it did not invent is the detection. What a reader still has to hold in the same hand is the size of the group, the design of the study, and the decade-long fight between cancer agencies and food-safety agencies over this same chemical.
Two days later, on 22 September 2026, the U.S. Environmental Protection Agency and the Department of Health and Human Services signed a new working pact to share data on glyphosate while EPA rewrites its human-health review, due in early 2027. That is the newest official move. Read the agency note: EPA and HHS announce partnership on the glyphosate review.
What the Hungarian team actually measured
Between 8 September 2023 and 19 June 2024 the team took blood serum and surgically removed womb-lining tissue from 34 women treated for, or strongly suspected of having, endometrial cancer. They matched them with 32 women of similar age and body mass who had benign womb conditions. They used an ELISA test adapted for solid tissue, not only blood.
Two results matter.
First, glyphosate in the tissue ran higher than glyphosate in the blood in every group — cancer and control. The womb lining held onto the chemical in a way a urine or blood screen would miss.
Second, when the team looked only at high-grade endometrial cancer — the aggressive form — both blood and tissue levels sat higher than in the control women. Women with low-grade tumours or pre-cancer changes did not show the same clear rise.
That high-grade group had six women. Six. The authors call the signal preliminary. They say the chemical may be a possible risk factor or co-factor. They do not say it caused the cancer. The study is a snapshot at the time of surgery. It cannot tell whether the weed killer arrived before the tumour or rode along after the tissue had already changed.
They also found a strong positive link between glyphosate in the tissue and zearalenone, a mould toxin that can act like estrogen. That pairing is easy to skip in a headline and hard to ignore in a hormone-sensitive organ.
“The chronic, low-level, combined presence of environmental contaminants quietly accumulating in the body’s tissues may matter more than high-dose acute exposure.” — framing used in the Defender account of the Hungarian paper.
That sentence is the alternative-media core. Mainstream briefs, when they cover weed killers at all, usually stay with farm workers, labels, and court awards. They rarely sit with the idea that a chemical used to dry wheat before harvest can lodge in the lining of a woman’s womb.
What other labs have already said about hormones and the womb
This paper did not appear in empty air.
In 2009, Céline Gasnier, Gilles-Éric Séralini and colleagues published in Toxicology that glyphosate-based mixes disrupted human cell lines at doses below farm spray strength. They reported effects on androgen and estrogen receptors and on aromatase, the enzyme that turns androgens into estrogens. The mix — the extra wetting agents in the bottle, not only the named active ingredient — drove much of the damage. The paper is here: Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.
Rat work has gone further into the uterus itself. A 2024 Frontiers in Toxicology study found that glyphosate and a full herbicide mix, given through pregnancy and nursing, changed the epigenetic marks on the womb gene Hoxa10 during the window when the lining must accept an embryo. That is mechanism talk, not a human cancer trial. It is still a reason the Hungarian tissue finding did not land as a shock among independent toxicologists.
Argentine groups have reported that glyphosate can change how womb cells grow and how the tissue is built. Reviews in reproductive journals have tied pesticide exposure, in different study designs, to polycystic ovary syndrome, endometriosis, and trouble conceiving. Those links are associations and animal signals. They are not a courtroom proof that one spray bottle produced one tumour.
Older human biomonitoring is less dramatic and more stubborn. A German urine survey in 2012, often cited in independent health writing, found glyphosate in people with no farm job. Other labs have reported the chemical in urine, blood, and, in some contested tests, breast milk. Pre-harvest spraying on wheat, barley and oats — used to dry the crop evenly — is the route that brings residues into bread and breakfast food, not only into fields of engineered soy. That farming habit is public. It is also the part of the file that “used as directed” language tends to leave in the barn.
FIGO, the world body for obstetricians, has warned for years that chemical exposures, including pesticides, now sit among the large threats to human reproduction. The World Health Organization has separately said environmental pollution, in the wide sense, kills large numbers of children each year and has urged cuts in agricultural chemicals. Those statements are about a class of harms, not about this one Hungarian sample set.
The split the public is not supposed to notice
In 2015 the International Agency for Research on Cancer, part of WHO, put glyphosate in Group 2A: probably able to cause cancer in humans. The judgement rested on limited human evidence, enough animal evidence, and strong evidence that the chemical can damage DNA. IARC asks a hazard question: can this substance cause cancer under some conditions?
The U.S. EPA has said glyphosate is “not likely to be carcinogenic to humans” when used as the label directs. EFSA, ECHA and several other national offices have landed closer to EPA than to IARC. They ask a risk question: at the doses people actually meet, is the chance high enough to change the licence?
Those are not the same exam. They can both be internally honest and still leave a woman with a tumour holding two official answers.
On 8 September 2026, ECHA’s Risk Assessment Committee looked at new rat data from the Ramazzini Institute’s long study (Panzacchi and colleagues, Environmental Health, 2025). That rat work reported more tumours, including blood cancers, at doses the EU treats as acceptable. ECHA still declined to class glyphosate as a carcinogen under EU hazard rules. Farm licences stay in force. The chemical stays in the shed.
EPA’s own page now says the cancer evaluation is being updated, with a human-health package expected in late 2026 or early 2027. On 22 September 2026 EPA and HHS agreed to pool lab strength for that review. HHS Secretary Robert F. Kennedy Jr. said the public has a right to know what the best science says about chemicals in food and work. EPA Administrator Lee Zeldin said the law already requires a fresh look on a cycle. Neither man, in that note, adopted the Hungarian paper as proof of cause.
In June 2026 the U.S. Supreme Court sided with the Roundup maker in a fight over state cancer warnings on labels, on the ground that EPA has long declined to require such a warning. Bayer, which bought Monsanto, still faces a mountain of claims that the product caused non-Hodgkin lymphoma. Juries have gone both ways. Settlements have been huge. The science fight did not end when the cheques were signed.
In December 2025 a journal retracted a much-cited safety paper that had leaned on unpublished Monsanto studies and, the journal said, may have been ghost-written. Regulators had used that paper. Retraction does not by itself prove the opposite claim. It does show why trust in the “safe when used as directed” line is thinner than a press office wants.
What mass desks leave out, and what other desks add
A careful newsroom will print: small sample; no cause shown; regulators split; more work needed. That is true. It is also incomplete in a specific way. It does not sit with the reader who eats bread made from wheat dried with this chemical, who has no farm job, and who now learns the lining of the womb can hold more of it than the blood.
Independent and alternative outlets add three claims that need sorting, not swallowing whole.
One: that detection equals guilt. The Hungarian authors refuse that leap. A chemical can be present because the tissue is sick, because the woman lives in a sprayed district, because diet is high in treated grain, or because the test cross-reacts. ELISA is useful and not the last word. Mass-spectrometry confirmation on a larger set would quiet that doubt.
Two: that every reproductive illness now traces to this one weed killer. PCOS, endometriosis, miscarriage and falling sperm counts have many drivers — age, weight, smoking, other plastics and pesticides, infection. Piling every sorrow onto glyphosate makes a clean story and a messy science.
Three: that agencies know and hide. Court files from the Monsanto litigation did show a company working the literature and the regulators. That is a documented corporate method. It is not the same as a secret that IARC, Ramazzini, Semmelweis and EPA are all reading from one script. The plainer reading is worse in a dull way: different offices use different rules, industry funds the studies that fill the licence file, and a woman’s tissue is not in that file until someone bothers to look.
The health file next door is the same pattern. Planet Today has already treated other body-burden stories the same way — measurement first, cause second — in the WHO warning that cancer cases may nearly double by 2050, Baltic kitchen anemia cures versus trial data, the sunscreen paradox in a huge UK biobank set, and trace hormone-blocking activity reported in some U.S. tap water.
What a reader can do with an unfinished fact
No honest article can tell a woman to empty her kitchen on the strength of six high-grade cases. No honest article can tell her the lining of the womb is a sealed room. The chemical is in food, water, dust and, now, in measured human endometrial tissue. High-grade disease tracked with higher levels in this small set. The authors asked for more work. That ask is the least controversial line in the paper.
Practical steps that do not require a courtroom win: wash and peel produce; cut back on foods known for pre-harvest drying sprays if you can find the supply chain; keep farm-work clothes out of the house; treat “inert” wetting agents in the bottle as part of the exposure, because cell work has said they are. None of that proves a tumour will fail to form. It treats the body as a place where low doses add up, which is the hypothesis the Hungarian team put on the table.
Doctors who see rising endometrial cancer in younger women already talk about weight, estrogen and delayed childbirth. They should also be able to say, without a campaign slogan, that a probable IARC carcinogen has now been quantified in the organ they cut. That sentence does not convict a company. It does convict the habit of waiting for a perfect study before mentioning the dust on the wheat.
The question the next paper has to answer
Was the weed killer in the tissue because the cancer was already there, or was the cancer more likely because the weed killer had been there for years? A cross-section cannot answer. A larger set with mass-spec confirmation, stored blood from years earlier, and clear farm and diet histories can get closer.
Until that paper exists, two voices will keep talking past each other. One says: licensed, reviewed, not likely to cause cancer at label use. The other says: it is in the womb, it is higher in the worst tumours, and the licence was built on a thinner file than the public was told. Both voices now have a citation from Budapest. Only one of them needed that citation to keep selling the spray.
The reader does not have to join a camp. The reader has to decide whether “not proven to cause” is the same comfort it was before someone looked inside the tissue.
Latest news on this file: EPA–HHS working pact, 22 September 2026 — EPA press release. Tissue study coverage, 21 September 2026 — Children’s Health Defense / The Defender.
Primary study: Unicsovics et al., “Presence of glyphosate in endometrial cancer tissue: A cross-sectional study,” Toxicology Reports 16 (2026) 102255 — ScienceDirect · PubMed.
Other primary sources: Gasnier et al., Toxicology, 2009 · EPA glyphosate page · IARC Monograph Volume 112 (2015), glyphosate Group 2A.
Related Planet Today reading: WHO: cancer cases could nearly double by 2050 · Baltic anemia kitchen cures vs trials · Sunscreen paradox, UK Biobank
Original date of this analysis: 24 September 2026.
Note for fact checkers: This article does not claim glyphosate has been proven to cause uterine cancer. The Hungarian study is cross-sectional, the high-grade cancer arm had six patients, and the authors describe a possible co-factor, not a cause. ELISA detection in tissue is a first-look method; independent labs have not yet published a large confirmatory series. IARC’s 2015 Group 2A classification and EPA’s “not likely carcinogenic” finding are both on the public record and use different questions. ECHA reaffirmed no carcinogen classification in September 2026 after reviewing the 2025 Ramazzini rat data. Bayer denies that Roundup causes cancer; litigation continues. Children’s Health Defense is an advocacy outlet; the underlying journal paper should be read beside the Defender summary. Figures and dates above follow the journal abstract, the Defender report of 21 September 2026, and the EPA release of 22 September 2026.
Original article: Glyphosate in Womb Tissue: What the New Cancer Study Shows on Planet Today 🚀
Automatically republished from the main blog.